Moreover, studies assessing proinsulin in pregnancy did not take into account individual risk factors which may account for varied findings.28 29 Therefore, we hypothesised that plasma proinsulin with its breakdown products (insulin and C-peptide) may potentially be used as early screening biomarkers to identify pregnant women with risk factors who will go on to develop GDM. Here, INS is linked to gestational diabetes.